logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Insulin Resistance As A Risk Factor In Visceral And Neurological Disorders Akhlaq A Farooqui

  • SKU: BELL-11095136
Insulin Resistance As A Risk Factor In Visceral And Neurological Disorders Akhlaq A Farooqui
$ 31.00 $ 45.00 (-31%)

5.0

78 reviews

Insulin Resistance As A Risk Factor In Visceral And Neurological Disorders Akhlaq A Farooqui instant download after payment.

Publisher: Academic Press Inc
File Extension: PDF
File size: 13.46 MB
Pages: 498
Author: Akhlaq A. Farooqui
ISBN: 9780128196038, 0128196033
Language: English
Year: 2020

Product desciption

Insulin Resistance As A Risk Factor In Visceral And Neurological Disorders Akhlaq A Farooqui by Akhlaq A. Farooqui 9780128196038, 0128196033 instant download after payment.

Insulin Resistance as a Risk Factor in Visceral and Neurological Disorders provides an overview on the risk factors for insulin resistance in visceral and neurological disorders. The book focuses on molecular mechanisms and signal transduction processes associated with the links. The comprehensive information in this monograph will not only help in the early detection of insulin resistance related visceral and neurological disorders, but also promote the discovery of new drugs which may block or delay onset in elderly patients. Understanding these processes is important not only for patients, caregivers and health professionals, but also for health policymakers who must plan for national resources.

Related Products